value-based pricing biotech

Commercialising a healthcare product in the United States requires far more than clinical validation. Success depends on aligning regulatory pathways, payer acceptance, provider adoption, and scalable market access strategies. Whether launching a novel biologic, diagnostic platform, or digital health solution, companies must navigate a complex ecosystem shaped by the FDA, CMS, and private payers. Early … Read more